Delivering global solutions
With more than a century of experience in satisfying both the fundamental and emerging needs of humans, we connect our biologics expertise with our chemical know-how to help our customers meet some of the world’s most pressing challenges. We are working to address critical global challenges that are forming at the intersection of four key megatrends:
- Growing world population
- Aging world populations
- Rapid growth of megacities
- Growth of middle classes in BRIC (Brazil, Russia, India and China) and VISTA (Vietnam, Indonesia, South Africa, Turkey and Argentina) countries
We are working to meet the escalating healthcare needs driven by these trends, both in our Pharma, Biotech & Nutrition and Specialty Ingredients segments. We excel at consistently delivering high quality products, providing tailored technical and regulatory support, and offering a broad portfolio of registered and approved actives to meet the world's most exacting regulatory standards.
Growing world population
As populations continue to grow and the middle classes expand rapidly in emerging countries and megacities, need is increasing for simple yet effective hygiene products to combat a broad range of pathogens, including harmful bacteria and viruses that are often present in healthcare facilities. Our sanitizers and disinfectants are used in hospitals and other medical settings, industrial cleanrooms, homes, restaurants, food preparation facilities, schools, offices, gyms and even cruise ships, across the world.
Our Nutrition and Agro businesses are addressing consumers’ growing needs for safe, healthy and abundant foods and nutrients. Custom-manufactured products help our customers optimize yields. We are also a world leader in molluscicides, with proprietary products that safely protect lettuce, other greens and rice from the damage caused by slugs and snails.
Aging world populations
The rapid growth in elderly populations is tied to the growing prevalence of cancer, heart disease, diabetes and many other age-related illnesses. Our Pharma, Biotech & Nutrition segment plays a major role in the development and manufacture of medicines that have the potential to extend and improve the quality of life in aging populations.
The need for effective yet reasonably priced medicines and therapies not only applies to BRIC and VISTA nations, but also to developed nations. We are a leader in helping customers create cost-effective medicines, in both small-molecule and biologic technologies. We are also a pioneer in the development of the most advanced, cutting-edge medicines and therapies in the world today, including cell and gene therapies.
Our Nutrition business addresses the needs of an aging population by providing active ingredients for active living. We’re developing our nutritional portfolio in areas of muscle health, weight maintenance, mobility (including joint health) alongside immune system and digestive health. Our consumer health businesses are at the forefront of helping people feel and look their best. The rapid growth of elderly populations in developed nations is driving increased demand for healthy foods, nutritional supplements, anti-aging cosmetics and other personal care products.
Rapid growth of megacities
The movement of populations from rural areas to megacities is generating a need for many products and services, including sustainable building products. Wood is one of the world’s most vital and renewable natural resources, and engineered wood is an advanced material that provides strength, durability and beauty in buildings.
Our wood businesses offer innovative technologies such as adding a preservative and water repellent property to our customers’ engineered timbers. They also offer cutting-edge products that combine fungicides and insecticides to protect engineered wood from insects and decay over time.
The threat of fire in densely developed cities helps explain the growing use of our fire-retardant treatments for wood in schools, apartment complexes, homes, train stations and hospitals.
Growth of middle classes in BRIC and VISTA countries
The growing middle classes in BRIC and VISTA countries will generate increasing demand for affordable medicines and access to innovative therapies. With leading facilities in Singapore and China, our Pharma, Biotech & Nutrition segment is working to meet this rising demand.
The climate in these nations can tend towards being hot and humid. Our coatings and composites businesses help to fight mold and ‘sick-building syndrome’ in facilities by providing protective biocides and fungicides for paints, wallboard, ceiling tiles, adhesives and other building products.